Alimentómica focuses its activity on the research and development of new components, technologies or innovative practices that make it possible to improve people's nutrition and health. We are especially interested in the advances in the prevention of obesity and its associated pathologies from the improvement of infant nutrition, since there is solid scientific evidence, to which our group has made important contributions, that nutritional factors in the former life stages can condition susceptibility to obesity and metabolic syndrome in adulthood.
Alimentómica is the first Technology-Based Company at the University of the Balearic Islands, it has a 10% share of the UIB in its capital stock.
Alimentómica is formed based on a human group of 12 professionals and more than 30 collaborators, with training and experience in disciplines that range from biotechnology and nutrigenomics to project management and business management.
The group of professionals that make up the Alimentomics research group is led by Professor Andreu Palou , a world leader in obesity and diet. The group has extensive experience in these fields, as evidenced by the set of studies, articles and patents that it has to its credit.
The main mission of Alimentómica is to transform the scientific-technological advances of its scientific group into ingredients or products available to society, to create value in a responsible, ethical and sustainable way, thus building a profitable business for our partners and shareholders.
Alimentómica's vision is to become a world benchmark in the biotechnology and nutrigenomics sector, capable of attracting interest and offering the necessary confidence to our clients to collaborate and lead the most innovative research and developments in the sector.
The Laboratory of Molecular Biology, Nutrition, and Biotechnology (LBNB) of the University of the Balearic Islands (UIB), made up of the research group on "Biochemistry, molecular biology, nutrition and biotechnology - Nutrigenomics", is the main contributor to Alimentomics .
Seven of its main members are partners of the company and collaborate actively in the development of projects promoted by the organization through collaboration contracts with the UIB. In addition, the director of the LBNB, Professor Andreu Palou, is in turn the president of the Scientific Committee on Alimentomics.
Research in the LBNB has focused for years on the study of the control mechanisms of weight and body adiposity, their alterations in obesity and their interactions with nutrients. It is a broad research topic that includes aspects such as appetite control, energy efficiency control and adaptive thermogenesis, control of preadipocyte proliferation and their differentiation into adipocytes (adipogenesis), the connections between excess adiposity and complications metabolic, and the genetics, epigenetics and nutrigenomics of body weight control, in addition to the relationships with functional nutrition and food safety and quality. The group has been addressing, over time, different aspects of this complex framework, incorporating new scientific and methodological advances and taking care not to lose a holistic vision.
The main lines of research of the group are therefore framed in the fields of Molecular Nutrition, Nutrigenomics and, in relation to this, the development of health claims in food ( health claims made on food ):
Nutrition, genes and pathologies. Obesity and cancer.
Nutrigenomics and personalized nutrition.
Functional foods for body weight regulation
Food safety and quality
The group has demonstrated its activity and research capacity in a large number of national and international projects. He is currently coordinator of a European project to identify early biomarkers of homeostatic robustness through the use of nutrigenomics (BIOmarkers of Robustness of Metabolic Homeostasis for Nutrigenomics-derived Health CLAIMS Made on Food (BIOCLAIMS) (FP7-244995)), which includes 11 outstanding European research centers. Likewise, it participates in other European projects aimed at promoting and evaluating the status of food reformulation for health in Europe (SALUS project), the analysis of determinants of eating behavior in European children and adolescents and their parents (IDEFICS projects and I. Family), and the connection between the thermogenic activity of brown and beige adipocytes and type II diabetes (DIABAT).
The group's scientific and research career has allowed it to consolidate, throughout its professional career, numerous working relationships with groups of excellence at a national and international level. Among them, it should be noted that the group is a founding member of the 'European Nutrigenomics Organization' (NuGO) and the Center for Biomedical Research in Network-Physiopathology of Obesity and Nutrition (CIBERobn).